Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Nov 7, 2022 · 10-Q · 38 days after period end · 0001069530-22-000058
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Net Income | -$20.26M | -$9.56M | -$1.43M | -$697.00K |
| EPS Diluted | — | -$0.24 | -$0.06 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 7, 2022 · 38 d after period end
